AffinityImmuno Inc.’s SARS-CoV-2 spike protein-ligand binding assay

We Biotechno labs have joined hands with AffinityImmuno to provide you Virus Neutralization kits. AffinityImmuno Inc. has been a premier supplier of reagents and services focused on providing support to biological drug research since 2014. In addition to a catalog of ELISA kits and monoclonal antibodies, AffinityImmuno Inc. provides a custom chicken polyclonal antibody service. Recently, AffinityImmuno Inc. has launched a series of reagents in response to the COVID19 pandemic which includes various polyclonal antibodies, virus spike protein ELISA kit, and a virus neutralization test.
AffinityImmuno Inc.’s SARS-CoV-2 spike protein-ligand binding assay (surrogate Virus Neutralization Test) allows rapid quantification of COVID-19 neutralizing antibodies in serum and plasma by measuring the reduction in binding of viral spike protein with its receptor ACE2. This assay allows rapid analysis of convalescent plasma, antibody-based therapeutics, vaccine leads, and immune response to the virus to measure the percent reduction in spike protein binding to ACE2. This serological platform was designed as a tool to understand the correlation between neutralizing antibody level and protective immunity in recovered SARS-CoV-2.

#healthcare #covid19 #biotechnology #cancer #innovation #medical #covid #medicaldevices #medicine #research #science #oncology #biotechnolabs #biotechnolab #labsupplies #laboratory #laboratoryequipment #labs #elisakit #sarscov2